|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| - | 1 | |||||||
| 10 | ||||||||
| 7 | ||||||||
| - | 1 | |||||||
| 10 | ||||||||
| 5 | ||||||||
| 2 | ||||||||
| 5 | ||||||||
| 3 | ||||||||
| - | - | |||||||
| - | - | |||||||
| Average | 5 | |||||||
| Weighted average by Cap. | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
















